- ►diabetesjournals.org SM Pop, CP Wong, Q He, Y Wang, MA Wallet, … - Diabetes, 2007 - Am Diabetes Assoc Antigen-specific immunotherapy, an approach to selectively block autoimmune
diabetes, generally declines in nonobese diabetic (NOD) mice as disease
progresses. To define the parameters influencing the efficacy of antigen- ... Cited by 17 - Related articles - BL Direct - All 5 versions
R Tisch - Am Diabetes Assoc The type and frequency of immunoregulatory CD4+ T cells govern the efficacy of
antigen- specific immunotherapy in diabetic NOD mice. ... Received for
publication 21 April 2006 and accepted in revised form 8 February 2007. Related articles
[CITATION] Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
- ►jimmunol.org AP Olcott, J Tian, V Walker, H Dang, B … - The Journal of Immunology, 2005 - Am Assoc Immnol As organ-specific autoimmune diseases do not become manifest until
well-advanced, interventive therapies must inhibit late-stage disease processes.
Using a panel of immunogenic peptides from various cell Ags, we evaluated ... Cited by 15 - Related articles - BL Direct - All 5 versions
- ►jimmunol.org C Seifarth, S Pop, B Liu, CP Wong, R Tisch - The Journal of Immunology, 2003 - Am Assoc Immnol Recurrent autoimmune destruction of the insulin-producing cells is a key factor
limiting successful islet graft transplantation in type I diabetic patients. In
this study, we investigated the feasibility of using an Ag-specific plasmid ... Cited by 18 - Related articles - BL Direct - All 5 versions
C Zhao, Z Wang, MW Robertson, JD Davies - Immunology, 2008 - pubmedcentral.nih.gov One of the long-term consequences of Type I diabetes is weight loss with muscle
atrophy, the hallmark phenotype of cachexia. A number of disorders that result
in cachexia are associated with immune deficiency. However, whether immune ... Cited by 1 - Related articles - All 5 versions
R Jonsson, KA Brokstad, T Hansen, T Davies, … - Scandinavian Journal of Immunology, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - BL Direct - All 4 versions
G Fousteri, D Bresson, M von Herrath - Advances in experimental medicine and biology, 2007 - Springer Abstract. Administration of autoantigens, especially via the mucosal route, can
induce toler- ance under certain circumstances. In autoimmune diabetes, mucosal
vaccination with autoan- tigens was frequently effective in restoring ... Cited by 3 - Related articles - BL Direct - All 5 versions
- ►nih.gov KS Goudy, B Wang, R Tisch - Clinical Immunology, 2008 - Elsevier Type 1 diabetes (T1D) is characterized by the T cell mediated destruction of the
insulin-producing β cells. Antigen-specific immunotherapies are used to
selectively tolerize β cell-specific pathogenic T cells either directly, ... Cited by 3 - Related articles - All 4 versions
CH Kim - Experimental hematology, 2006 - Elsevier FoxP3 + T cells play critical roles in regulation of the hematolymphoid system
and prevention of autoimmunity. Many FoxP3 + T cells, generated in thymus as the
result of T cell receptor (TCR) recognition of self antigens, ... Cited by 17 - Related articles - All 15 versions
